We developed a novel murine heart failure model (triple‐tg) by cross‐breeding calsequestrin transgenic mice with human renin and human angiotensinogen double‐transgenic mice and investigated the cardioprotective effect of imarikiren at clinically relevant doses. This evidence concerns the gene AGT and heart failure.